Alembic Pharmaceuticals Share Price Target 2025 to 2030: Hello Friends, today we are going to give you complete information about Alembic Pharmaceuticals Share Price. If you want to know what is the future of this Share Price and what is its target? So we will give you complete information about this Share in detail.
Alembic Pharmaceuticals Share Price Target
If we talk about Alembic Pharmaceuticals Share Price Target, then its share is going to increase in the coming 10 years. Talking about its performance, this stock has performed well in the last few months and has given money to all the investors. Investors of this Share are increasing very fast and all the investors are also investing funds. If you are a long-term investor then this share will give you good returns.
Alembic Pharmaceuticals Company Details
Alembic Pharmaceuticals Limited, which is based in India, operates in the pharmaceutical industry. The Company engages in the production and promotion of Active Pharmaceutical Ingredients (API), International Generics, and India Formulations. It provides a varied and growing selection of generics across chronic segments. Its treatments encompass Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopaedic and Gynaecology.
Fundamental Details
- P/E Ratio (TTM): 33.98
- EPS (TTM): 29.68
- Dividend Yield: 1.09%
- Market Cap: ₹19,821Cr
Financial Details
| 2021 | 2022 | 2023 | 2024 | 2025 | |
| Revenue | Rs. 5,480 Cr | Rs. 5,356 Cr | Rs. 5,655 Cr | Rs. 6,257 Cr | Rs. 6,715 Cr |
| Profit | Rs. 1,115 Cr | Rs. 521 Cr | Rs. 342 Cr | Rs. 616 Cr | Rs. 582 Cr |
| Net Worth | Rs. 5,067 Cr | Rs. 5,238 Cr | Rs. 4,370 Cr | Rs. 4,818 Cr | Rs. 5,190 Cr |
Alembic Pharmaceuticals Share Price Target 2025 to 2030
Alembic Pharmaceuticals Share Price Target 2025 ₹1097.63, 2026 ₹1234.51, 2027 ₹1387.49, 2028 ₹1522.67, 2029 ₹1684.31, 2030 ₹1842.59.
| Alembic Pharmaceuticals Share Price Target | Price |
| Alembic Pharmaceuticals Share Price Target 2025 | ₹1097.63 |
| Alembic Pharmaceuticals Share Price Target 2026 | ₹1234.51 |
| Alembic Pharmaceuticals Share Price Target 2027 | ₹1387.49 |
| Alembic Pharmaceuticals Share Price Target 2028 | ₹1522.67 |
| Alembic Pharmaceuticals Share Price Target 2029 | ₹1684.31 |
| Alembic Pharmaceuticals Share Price Target 2030 | ₹1842.59 |
Alembic Pharmaceuticals Share Price Target 2025
If we predict Alembic Pharmaceuticals Share for 2025, then looking at the growth of this share, the expectation is that this share will increase the money of all the investors and will give profit to all the investors. Looking at the market growth of this share, it is expected that this share will grow from Upto ₹1097.63 by the end of 2025. Alembic Pharmaceuticals Share Price Target for 2025 is ₹1097.63.
| Alembic Pharmaceuticals Share Price Target 2025 | ₹1097.63 |
Alembic Pharmaceuticals Share Price Target 2030
Talking about Alembic Pharmaceuticals Share, this share is on a bullish trend every year and the year ending of this share is with profit only. If we talk about 2030, then it is expected that this share will close upto ₹1842.59 this year. Looking at the bullish trend of this stock, it is expected that this year too it will add profit by making the money of all its investors profitable. Alembic Pharmaceuticals Share Price Target for 2030 is ₹1842.59.
| Alembic Pharmaceuticals Share Price Target 2030 | ₹1842.59 |
| Disclaimer: This article is for informational purposes only and should not be considered investment advice. The price targets or predictions provided are generated by a custom algorithm using deep learning, which may change due to market fluctuations, volume shifts, and market cycles. It is strongly recommended not to base investments solely on the target price mentioned. |
I’m Rakesh Goswami, a Computer Science engineer with over 5 years of experience in blogging. I specialize in stock market research and share price target analysis. Through this website, I aim to provide clear and reliable insights to help readers make informed investment decisions.